EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 157 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $923,035 | -36.3% | 58,531 | -21.4% | 0.01% | -30.0% |
| Q2 2023 | $1,448,441 | +34.1% | 74,508 | +95.7% | 0.01% | +42.9% |
| Q1 2023 | $1,079,989 | +497.2% | 38,068 | +515.3% | 0.01% | +600.0% |
| Q4 2022 | $180,846 | -57.8% | 6,187 | -35.9% | 0.00% | -66.7% |
| Q2 2022 | $429,000 | -31.6% | 9,658 | -23.8% | 0.00% | -40.0% |
| Q1 2022 | $627,000 | +47.9% | 12,679 | +52.3% | 0.01% | +25.0% |
| Q4 2021 | $424,000 | -40.0% | 8,323 | -34.4% | 0.00% | -55.6% |
| Q3 2021 | $707,000 | +98.0% | 12,680 | +52.1% | 0.01% | +125.0% |
| Q2 2021 | $357,000 | -46.6% | 8,334 | -47.9% | 0.00% | -55.6% |
| Q1 2021 | $668,000 | +66.6% | 16,001 | +86.1% | 0.01% | +50.0% |
| Q4 2020 | $401,000 | +61.0% | 8,600 | +46.6% | 0.01% | +50.0% |
| Q3 2020 | $249,000 | -0.8% | 5,866 | +7.4% | 0.00% | -42.9% |
| Q1 2020 | $251,000 | -24.4% | 5,463 | -6.8% | 0.01% | 0.0% |
| Q3 2019 | $332,000 | -31.3% | 5,862 | -32.4% | 0.01% | -22.2% |
| Q2 2019 | $483,000 | +13.1% | 8,677 | +2.5% | 0.01% | -35.7% |
| Q1 2019 | $427,000 | -54.9% | 8,463 | -64.0% | 0.01% | -68.9% |
| Q4 2018 | $947,000 | +142.2% | 23,506 | +258.7% | 0.04% | +104.5% |
| Q3 2017 | $391,000 | +33.9% | 6,554 | +77.0% | 0.02% | +15.8% |
| Q2 2017 | $292,000 | +421.4% | 3,702 | +168.7% | 0.02% | +533.3% |
| Q1 2016 | $56,000 | -80.9% | 1,378 | -65.2% | 0.00% | -80.0% |
| Q3 2015 | $293,000 | 0.0% | 3,962 | +9.5% | 0.02% | +7.1% |
| Q2 2015 | $293,000 | -73.1% | 3,618 | -86.1% | 0.01% | -73.6% |
| Q1 2015 | $1,088,000 | – | 25,972 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |